Goldman Sachs
GMO

Goldman Sachs’s General Moly, Inc. GMO Stock Holding History

Goldman Sachs’s Portfolio GMO Stock Details GMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23,971
Closed -$5K – 5650
2020
Q2 		$5K Buy
+23,971
New +$4.74K ﹤0.01% 5158
2018
Q4 		– Sell
-34,334
Closed -$13K – 5868
2018
Q3 		$13K Buy
34,334
+4,946
+17% +$1.93K ﹤0.01% 5456
2018
Q2 		$12K Buy
29,388
+5
+0% +$2 ﹤0.01% 5534
2018
Q1 		$11K Sell
29,383
-739
-2% -$289 ﹤0.01% 5745
2017
Q4 		$10K Buy
30,122
+180
+0.6% +$57 ﹤0.01% 6211
2017
Q3 		$11K Sell
29,942
-60,905
-67% -$25.7K ﹤0.01% 6528
2017
Q2 		$34K Sell
90,847
-4,751
-5% -$1.63K ﹤0.01% 6456
2017
Q1 		$48K Sell
95,598
-11,910
-11% -$5.72K ﹤0.01% 6302
2016
Q4 		$27K Buy
107,508
+389
+0.4% +$101 ﹤0.01% 6570
2016
Q3 		$30K Sell
107,119
-9,483
-8% -$3.02K ﹤0.01% 6642
2016
Q2 		$40K Buy
116,602
+86,128
+283% +$31.2K ﹤0.01% 6502
2016
Q1 		$10K Sell
30,474
-714
-2% -$170 ﹤0.01% 6903
2015
Q4 		$6K Sell
31,188
-3,659
-11% -$997 ﹤0.01% 7039
2015
Q3 		$10K Sell
34,847
-250
-0.7% -$122 ﹤0.01% 7143
2015
Q2 		$25K Sell
35,097
-5,478
-14% -$3.9K ﹤0.01% 7047
2015
Q1 		$21K Sell
40,575
-70,669
-64% -$36K ﹤0.01% 6898
2014
Q4 		$63K Sell
111,244
-20,918
-16% -$11.8K ﹤0.01% 6743
2014
Q3 		$98K Buy
132,162
+53,635
+68% +$52.5K ﹤0.01% 6589
2014
Q2 		$90K Sell
78,527
-3,328
-4% -$3.47K ﹤0.01% 6597
2014
Q1 		$81K Sell
81,855
-5,371
-6% -$6.52K ﹤0.01% 6454
2013
Q4 		$117K Buy
87,226
+62,345
+251% +$89.5K ﹤0.01% 6220
2013
Q3 		$41K Sell
24,881
-32,214
-56% -$58.1K ﹤0.01% 6347
2013
Q2 		$107K Buy
+57,095
New +$112K ﹤0.01% 5853

Other funds holding GMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Goldman Sachs's GMO Position: Q3 2020 in Review

Goldman Sachs sold out of General Moly, Inc. (GMO) in Q3 2020, closing a stake of 23,971 shares — an estimated $5K sold.

Goldman Sachs first reported a position in GMO in Q2 2013 and held it in 23 quarters. The position peaked at $117K in Q4 2013. 31 funds tracked by Wall St. Rank hold GMO as of Q3 2020.

  • Goldman Sachs reported no remaining General Moly, Inc. position as of Q3 2020 after selling out during the quarter.
  • Goldman Sachs sold 23,971 General Moly, Inc. shares in Q3 2020, an estimated $5K.
  • Goldman Sachs first reported a position in General Moly, Inc. in Q2 2013 and held it in 23 quarters.
  • Goldman Sachs's General Moly, Inc. position peaked at $117K in Q4 2013.
  • 31 funds tracked by Wall St. Rank held General Moly, Inc. as of Q3 2020.

Based on Goldman Sachs's 13F filing for Q3 2020, filed 13 Nov 2020.